0000899243-18-009111.txt : 20180402 0000899243-18-009111.hdr.sgml : 20180402 20180402200750 ACCESSION NUMBER: 0000899243-18-009111 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180329 FILED AS OF DATE: 20180402 DATE AS OF CHANGE: 20180402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schwartz Jonathan David CENTRAL INDEX KEY: 0001726398 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36829 FILM NUMBER: 18731000 MAIL ADDRESS: STREET 1: 430 EAST 29TH STREET STREET 2: SUITE 1040 CITY: NEW YORK STATE: NY ZIP: 10016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ROCKET PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001281895 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 430 EAST 29TH STREET STREET 2: SUITE 1040 CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 646-440-9100 MAIL ADDRESS: STREET 1: 430 EAST 29TH STREET STREET 2: SUITE 1040 CITY: NEW YORK STATE: NY ZIP: 10016 FORMER COMPANY: FORMER CONFORMED NAME: INOTEK PHARMACEUTICALS CORP DATE OF NAME CHANGE: 20040226 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-29 0 0001281895 ROCKET PHARMACEUTICALS, INC. RCKT 0001726398 Schwartz Jonathan David C/O ROCKET PHARMACEUTICALS, INC. 430 EAST 29TH STREET, SUITE 1040 NEW YORK NY 10016 0 1 0 0 Chief Medical Officer Stock Option (Right to Buy) 18.75 2018-03-29 4 A 0 60000 0.00 A 2028-03-29 Common Stock 60000 60000 D This option represents a right to purchase a total of 60,000 shares of the Issuer's Common Stock, 20,000 of which will become fully vested and exercisable on March 29, 2019, with the remaining 40,000 shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer. /s/ Alice Lee, as attorney-in-fact for Jonathan Schwartz 2018-04-02